Shire homes in
What convinced Shire to snag Arrowhead peptide platform to target rare diseases
Last week, the companies partnered to use Arrowhead's Homing Peptide technology to discover peptide-drug conjugates. Arrowhead will identify peptides that selectively target an undisclosed tissue type, and Shire will provide the therapeutic payload.
Shire will have an option to license rights to develop and commercialize conjugates discovered under the deal. Arrowhead